3‐Substituted Triazolone–Benzoate Hybrids: Synthesis, Enzyme Inhibition, Anticancer Activity and ADMET Evaluation by Molecular Docking and Dynamics Studies
Drug Development Research · 2026-02 · 87 (1)
DOI: 10.1002/ddr.70222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 30.12.2025. Verfasst von Murat Beytur und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science and Letters, Kafkas University, Kars, Türkiye. Hauptthemen laut MEDLINE: Antineoplastic Agents, Triazoles, Benzoates. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
In this study, eight 3‐substitued ‐4‐amino‐4,5‐dihydro‐1 H ‐1,2,4‐triazol‐5‐one compounds were synthesized. The reactions of these compounds with 2‐ethoxy‐4‐formylphenyl benzoate, which was synthesized by the reaction of 3‐ethoxy‐4‐hydroxy benzaldehyde with benzoyl chloride by using triethylamine, were investigated. Eight novel 2‐ethoxy‐4‐(((3‐substitued‐5‐oxo‐1,5‐dihydro‐4H‐1,2,4‐triazol‐4‐yl)imino)methyl)phenyl benzoate compounds were obtained in order to identify the new synthesized compounds by spestroscopic methods including IR, 1 H‐NMR and 13 C‐NMR used. Concentration ranges of 25, 50, 120, 200, and 400 µg/mL were applied to determine the compund's anti‐cancer properties. The human ovarian cancer cell line (OVCAR‐3) compared with human umbilical vein endothelial cells (HUVEC) and significant results were obtained against the OVCAR‐3 cell line. The enzyme inhibitory effect of compound on glutathione S‐transferase (GST), acetylcholinesterase (AChE) enzymes were studied. Ki and IC 50 values were found in the range of 1.1143 ± 0.2402 µM–7.9100 ± 1.9107 µM and 1.840 µM–4.149 µM for AChE; 2.0733 ± 0.8199 µM–8.2120 ± 1.5720 µM and 1.320 µM–3.223 µM for GST. In silico ADMET and drug‐likeness analyses confirmed favorable pharmacokinetic and drug‐like profiles for the compounds. Additionally, molecular docking and 100 ns molecular dynamics (MD) simulations revealed stable binding modes and dynamic stability of the most active compounds with the target enzymes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Science and Letters, Kafkas University, Kars, Türkiye.
- Department of Medical Services and Techniques, Vocational School of Health Services, Iğdır University, Iğdır, Türkiye.
- Department of Medical Services and Techniques, Vocational School of Health Services, Bitlis Eren University, Bitlis, Türkiye.
- Department of Chemical Engineering, Faculty of Engineering and Architecture, Kafkas University, Kars, Türkiye.
- Department of Basic Sciences, Faculty of Dentistry, Iğdır University, Iğdır, Türkiye.
- Department of Basic Medical Science, Medical Faculty, Nakhchivan State University, Nakhchivan, Azerbaijan.
ORCID-Profile: Fikret Türkan
Zitieren
APA
Beytur, M., Tarmaşır, E., Oguz, E., Bayrakdar, A., Sabancılar, İ., Akyildirim, O., Türkan, F., Aras, A., & Yüksek, H. (2026). 3‐Substituted Triazolone–Benzoate Hybrids: Synthesis, Enzyme Inhibition, Anticancer Activity and ADMET Evaluation by Molecular Docking and Dynamics Studies. Drug Development Research, 87(1). https://doi.org/10.1002/ddr.70222
Vancouver
Beytur M, Tarmaşır E, Oguz E, Bayrakdar A, Sabancılar İ, Akyildirim O, et al. 3‐Substituted Triazolone–Benzoate Hybrids: Synthesis, Enzyme Inhibition, Anticancer Activity and ADMET Evaluation by Molecular Docking and Dynamics Studies. Drug Development Research. 2026;87(1). doi:10.1002/ddr.70222
BibTeX
@article{Beytur2026,
author = {Beytur, Murat and Tarmaşır, Elif and Oguz, Ercan and Bayrakdar, Alpaslan and Sabancılar, İlhan and Akyildirim, Onur and Türkan, Fikret and Aras, Abdülmelik and Yüksek, Haydar},
title = {3‐Substituted Triazolone–Benzoate Hybrids: Synthesis, Enzyme Inhibition, Anticancer Activity and ADMET Evaluation by Molecular Docking and Dynamics Studies},
journal = {Drug Development Research},
year = {2026},
volume = {87},
number = {1},
doi = {10.1002/ddr.70222}
}
EUVIMED